Weekly News Recap #Phispers | PharmaCompass.com

Lundbeck acquires Longboard for US$ 2.6 billion; Roche’s Itovebi bags FDA nod for breast cancer

This week’s is a double dose Phispers, as we return from a one-week break due to CPhI Worldwide. The fortnight saw severa...

Impressions : 594

BMS med wins landmark FDA nod for schizophrenia; Sanofi’s Dupixent approved to treat COPD

In this week’s Phispers, the US Food and Drug Administration (FDA) approved Bristol Myers Squibb’s groundbreaking s...

Impressions : 675

Sanofi gets two bids valuing its consumer unit at US$ 17 bn; Pfizer pulls SCD drug from market

In news this week, Sanofi is considering the sale of its consumer health unit and has received binding bids valuing the divisi...

Impressions : 992

FDA panel votes against Intercept’s liver med Ocaliva; Lilly’s Ebglyss wins approval for eczema

Intercept Pharmaceuticals faced a major setback as a US Food and Drug Administration (FDA) panel voted against the confirmato...

Impressions : 887

GSK’s COPD, long-acting asthma drugs score late-stage wins; Novo’s weight-loss drug Saxenda found to be safe in kids

GSK scored a significant late-stage win with its asthma drug Nucala in treating chronic obstructive pulmonary disease (COPD). I...

Impressions : 562

FDA approves Emergent’s smallpox vaccine for mpox; Lilly inks up to US$ 1 bn deal with Haya to target obesity

This week saw the US Food and Drug Administration (FDA) respond to the global monkeypox (mpox) public health emergency by expan...

Impressions : 925

Lilly, Pfizer move to sell drugs directly to consumers; blast at Indian drug factory kills 17

An Indian factory that makes drugs for export to the US and other Western nations saw an explosion, caused by a chemical solven...

Impressions : 1435

IRA price talks conclude, three meds dominate savings; Gilead’s Livdelzi from CymaBay buyout gets FDA okay

This week, the Biden-Harris Administration said it has concluded price negotiations for 10 drugs under the Inflation Reduction ...

Impressions : 593

FDA rejects first MDMA therapy to treat PTSD; Merck, Curon ink up to US$ 1.3 bn deal for next-gen bispecific antibody

The US Food and Drug Administration (FDA) has declined to approve an MDMA-assisted therapy from Lykos Therapeutics to treat pos...

Impressions : 1260

FDA approves first ever T-cell receptor gene therapy from Adaptimmune, Servier’s brain tumor pill

This week, Adaptimmune clinched gold when it secured the first-ever US Food and Drug Administration (FDA) approval for a T-cell...

Impressions : 764

Boehringer boosts immune-oncology pipeline with US$ 1.3 bn Nerio buy; Pfizer adds US$ 1 bn to 2024 outlook

This week, the world’s largest private pharma company, Boehringer Ingelheim, acquired Nerio Therapeutics for up to US$ 1....

Impressions : 661

Merck’s RSV jab shows efficacy in infants; Novo-Lilly weight loss rivalry intensifies as China okays tirzepatide

This was a week when the US President Joe Biden ended his reelection bid, after giving America the Inflation Reduction Act that...

Impressions : 901

US Senate passes bipartisan bill to cut pharma patent abuses; Ipsen inks another ADC deal

This week, a bill heralded as “critical” to help “end anti-competitive practices” was passed by the US ...

Impressions : 1146

Lilly to acquire IBD drug developer Morphic for US$ 3.2 bn; Pfizer’s R&D chief to step down

This week saw Eli Lilly strike yet another deal as it announced the acquisition of Morphic Holding for about US$ 3.2 billion, t...

Impressions : 907

Lilly’s Alzheimer’s drug gets FDA nod; GSK buys rights to mRNA vaccines from Curevac for US$ 1.56 bn

This week, the US Food and Drug Administration (FDA) finally approved Eli Lilly’s Alzheimer’s drug donanemab after ...

Impressions : 714

Novo invests US$ 4.1 bn to boost Wegovy, Ozempic supply; Verona’s COPD therapy bags FDA nod

This week saw a couple of developments in the lucrative US market for glucagon-like peptide-1 (GLP-1) drugs that treat diabetes...

Impressions : 868

Merck wins FDA nod for pneumococcal vaccine; Roche partners Ascidian to develop novel gene therapies

This week saw the US Food and Drug Administration (FDA) approve Merck’s next-generation pneumococcal vaccine for adults. ...

Impressions : 985

FDA panel backs Lilly’s Alzheimer’s drug; agency approves Ipsen’s med to treat rare liver disease

The US Food and Drug Administration’s (FDA) advisory committee has voted unanimously in favor of the benefits of Eli Lill...

Impressions : 741

Astra’s cancer drugs impress at ASCO; Moderna’s mRESVIA becomes first mRNA RSV vaccine approved by FDA

This week saw the American Society of Clinical Oncology (ASCO) annual meeting in Chicago where cancer researchers presented det...

Impressions : 794

Lilly to invest additional US$ 5.3 bn to boost obesity drug supply; FDA panel votes against Novo’s weekly insulin

This week’s Phispers comes packed with news of investments, acquisitions, deals and trials. Eli Lilly has more than doubl...

Impressions : 1213

Astra targets US$ 80 bn revenue by 2030, invests US$ 1.5 bn in ADC plant; Lilly’s weekly insulin scores late-stage wins

In this week’s news, AstraZeneca has laid out an ambitious plan to achieve US$ 80 billion in revenue by 2030. The drugmak...

Impressions : 563

France draws US$ 2.25 bn investment from Big Pharma; Sanofi strikes US$ 1.2 bn deal with Novavax

In this week’s news, France attracted investments from pharma majors such as Sanofi, Pfizer, AstraZeneca and GSK during t...

Impressions : 882

FDA to consider psychedelic-assisted drug for treating PTSD; Novartis buys Mariana Oncology for up to US$ 1.75 bn

Last year, the US Food and Drug Administration (FDA) had published a new draft guidance for researchers investigating the use o...

Impressions : 654

FTC disputes relevance of over 300 patent listings; Japan’s Ono to buy Deciphera for US$ 2.4 bn

The price of drugs is the highest in the US, and the White House has been working on bringing down drug prices for several year...

Impressions : 869

ImmunityBio bags maiden FDA nod for bladder cancer; Ipsen, Skyhawk partner to develop neurological therapies

This week’s Phispers comes packed with news about drug approvals by the US Food and Drug Administration (FDA). The agency...

Impressions : 686

US panel accuses China of subsidizing fentanyl production; Nigeria introduces 5-in-1 meningitis vaccine

This week’s news brings a mix of promising advancements and concerning issues. A majority of opioid overdose deaths...

Impressions : 1439

Vertex buys Alpine Immune Sciences for US$ 4.9 billion; Merck KGaA signs ADC deal with AI biotech Caris

This week’s Phispers comes packed with deals, approvals and trial wins. Vertex Pharmaceuticals has decided to bet big on ...

Impressions : 1288

Genmab buys ProfoundBio for US$ 1.8 bn; FDA okays Vanda’s Fanapt to treat bipolar disorder

April kicked off with Danish drugmaker Genmab buying ProfoundBio for US$ 1.8 billion in cash. ProfoundBio is a clinical stage b...

Impressions : 792

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass